Infections pose an increasing risk to hospitalized patients. In collaboration with a number of partners, the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB has developed a new therapeutic approach ...
Sep 1, 2020
0
2
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumor cells and suppresses the immune system. This was discovered by scientists at the German Cancer Research Center (DKFZ) and the Berlin Institute ...
Aug 20, 2020
0
82
Permanent hearing loss triggered by a common chemotherapy drug in half of children being treated for cancer may occur through a well-studied immune receptor, according to University of Alberta research.
Aug 17, 2020
0
2
Any new infectious disease poses unique challenges to people who are pregnant during an outbreak. The effects of SARS, Zika and influenza in pregnancy highlight the potential immediate and longer term detrimental health outcomes ...
Aug 14, 2020
0
4
According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment.
Aug 12, 2020
0
232
Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad and her colleagues describe a newly understood way by which breast cancer cells sabotage a key player in the body's immune system. That key player provides ...
Jul 15, 2020
0
1
Chimeric antigen receptor (CAR) T cell therapy is a new and in some cases highly effective form of immunotherapy to treat certain types of cancer of the blood and lymph system. This promising treatment comes at a cost, however: ...
Jun 23, 2020
0
0
From the first reports coming out of Wuhan, Iran and later Italy, we knew that losing your sense of smell (anosmia) was a significant symptom of the disease. Now, after months of reports, both anecdotal and more rigorous ...
Jun 19, 2020
0
3
Chimeric antigen receptor (CAR) T cells have transformed the treatment of refractory blood cancers. These genetically engineered immune cells seek out and destroy cancer cells with precision. Now, scientists at Memorial Sloan ...
Jun 17, 2020
0
142
Developing a vaccine is difficult at the best of times, but rarely have we been in a situation where basic knowledge about a virus has to be acquired so directly alongside the race to eradicate it. To understand how difficult ...
Jun 11, 2020
0
10
